EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/27/2026
Back to search
Official data from USPTO
COMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS.
ST13
US500000087565901Class
35, 42, 44, 45
Filing
87565901
Registration
5602592
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/29/2026
Trademark type
Word
Nice classes
35, 42, 44, 45
Filing date
08/11/2017
Registration date
11/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2024
Last transaction
03/29/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/20/2017
First use in commerce
01/01/2018
Drawing code
4
Owner type
16
Owner location
Raleigh, NC, US
Examiner
SANTOMARTINO, MARTHA L
Current location
Historical data usage
Holders and representatives
Holders
ProPharma Group Holdings, LLC
ProPharma Group Holdings, LLC
Representatives
Dianne M. Smith-Misemer HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business information and business consulting servicesproviding business advisory services to identifyscreenselect contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providersdesigning the administrativefinancial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developingimplementing and evaluating patient care plans; Business servicestracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for business purposes
Class 42
Providing quality assurance services in the medicalpharmaceuticalbiotechnology fields; Quality management servicesquality evaluation and analysisquality assurancequality controlin the medicalpharmaceuticalbiotechnology fields; Testinganalysisevaluation of medicalpharmaceuticalbiotechnology services to assure compliance with industry standards; Tracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for quality control purposes
Class 44
Consulting services in the medicalpharmaceuticalbiotechnology fields; providing medical and pharmaceutical information servicesdrug interaction call centersadverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical informationconsultancy and advisory services; health care consultingaggregating clinicalclaimssocioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patientscohorts of patientspopulations; health care consultingassessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files; providing medical informationconsultancyadvisory servicesproviding healthcare providersinsurance companieshealthcare product manufacturers with information and statistics regarding patient medication intakeschedule compliancehealth status
Class 45
Regulatory compliance consulting in the pharmaceuticalbiotechnologymedical fields; Regulatory compliance consulting in the fields of drug and device development and manufacturing; Tracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes
Publications
History of USPTO decisions and trademark events.
43 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/27/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/27/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/23/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/23/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/23/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/23/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/03/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/27/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/06/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/02/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/01/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/08/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/07/2018
IUAF
USE AMENDMENT FILED
08/09/2018
EISU
TEAS STATEMENT OF USE RECEIVED
08/09/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2018
PUBO
PUBLISHED FOR OPPOSITION
02/06/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/17/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/30/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
12/30/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/30/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
12/30/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/30/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/21/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2017
GNRT
NON-FINAL ACTION E-MAILED
11/15/2017
CNRT
NON-FINAL ACTION WRITTEN
11/15/2017
DOCK
ASSIGNED TO EXAMINER
11/14/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2017
ALIE
ASSIGNED TO LIE
08/31/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2017
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/15/2017
NWAP
NEW APPLICATION ENTERED
08/15/2017
Continuous trademark protection
Get notified about every new filing that threatens COMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.